Caxton Associates (New York) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$521M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$149M |
| 3 |
Eli Lilly
LLY
|
+$74.8M |
| 4 |
Gilead Sciences
GILD
|
+$60.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$21.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$17M |
| 3 |
Broadcom
AVGO
|
+$16.6M |
| 4 |
Marvell Technology
MRVL
|
+$14.3M |
| 5 |
T-Mobile US
TMUS
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.98% |
| 2 | Technology | 3.97% |
| 3 | Financials | 3.94% |
| 4 | Consumer Discretionary | 2.88% |
| 5 | Industrials | 1.77% |
Similar funds
Caxton Associates (New York)'s Q4 2022 Portfolio in Review
As of Q4 2022, Caxton Associates (New York) held 659 positions worth $1.5B, up 100% from $751M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Caxton Associates (New York) deployed $681M of net new capital in Q4 2022, opening 195 new positions and adding to 97 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Amazon, an estimated $21.3M trimmed.
- Caxton Associates (New York)'s largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.
- Caxton Associates (New York) added most to Visa in Q4 2022, an estimated $13M increase.
- Caxton Associates (New York)'s biggest Q4 2022 reduction was Amazon, cutting an estimated $21.3M.
- Caxton Associates (New York) fully exited Broadcom in Q4 2022, selling an estimated $16.6M.
- Caxton Associates (New York)'s ten largest holdings make up 72% of its $1.5B portfolio in Q4 2022.
- Caxton Associates (New York) opened 195 new positions and closed 226 in Q4 2022.
- Caxton Associates (New York)'s portfolio value rose 100% quarter-over-quarter to $1.5B.
Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.